ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,569.90
0.00%
S&P ASX All Technology
2,968.80
0.00%
Brent Oil
83.54
-2.74%
US Dollar vs AUD
1.53207
-0.78%
Bitcoin
57,830.03
-4.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTX)

  7. BriaCell Therapeutics Corporation (BCTX) News

BCTX

BriaCell Therapeutics (BCTX)

BriaCell Therapeutics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCTX
DateTimeSourceHeadlineSymbolCompany
24/04/202422:00GlobeNewswire Inc.BriaCell Announces Oral and Poster Presentations at ASCO 2024NASDAQ:BCTXBriaCell Therapeutics Corporation
10/04/202422:00GlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
09/04/202422:00GlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXBriaCell Therapeutics Corporation
08/03/202400:00GlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXBriaCell Therapeutics Corporation
07/03/202400:00GlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXBriaCell Therapeutics Corporation
28/02/202400:00GlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXBriaCell Therapeutics Corporation
08/02/202400:00GlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXBriaCell Therapeutics Corporation
07/02/202400:30GlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXBriaCell Therapeutics Corporation
01/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCTXBriaCell Therapeutics Corporation
01/02/202409:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
31/01/202414:48GlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXBriaCell Therapeutics Corporation
23/01/202409:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCTXBriaCell Therapeutics Corporation
10/01/202408:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BCTXBriaCell Therapeutics Corporation
09/01/202403:01Edgar (US Regulatory)Form SCHEDULE 13G -NASDAQ:BCTXBriaCell Therapeutics Corporation
05/01/202400:45GlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
29/12/202300:55GlobeNewswire Inc.BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsNASDAQ:BCTXBriaCell Therapeutics Corporation
21/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
21/12/202300:40GlobeNewswire Inc.BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient SubsetNASDAQ:BCTXBriaCell Therapeutics Corporation
15/12/202309:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCTXBriaCell Therapeutics Corporation
15/12/202309:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
07/12/202301:31GlobeNewswire Inc.BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSNASDAQ:BCTXBriaCell Therapeutics Corporation
07/12/202301:00GlobeNewswire Inc.BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitNASDAQ:BCTXBriaCell Therapeutics Corporation
30/11/202323:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXBriaCell Therapeutics Corporation
30/11/202323:00GlobeNewswire Inc.BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNASDAQ:BCTXBriaCell Therapeutics Corporation
03/11/202323:31GlobeNewswire Inc.BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNASDAQ:BCTXBriaCell Therapeutics Corporation
26/10/202300:15GlobeNewswire Inc.BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateNASDAQ:BCTXBriaCell Therapeutics Corporation
21/10/202300:15GlobeNewswire Inc.October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyNASDAQ:BCTXBriaCell Therapeutics Corporation
19/10/202300:00GlobeNewswire Inc.BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) ConferencesNASDAQ:BCTXBriaCell Therapeutics Corporation
12/10/202300:10GlobeNewswire Inc.BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo ClinicNASDAQ:BCTXBriaCell Therapeutics Corporation
05/10/202300:00GlobeNewswire Inc.BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast CancerNASDAQ:BCTXBriaCell Therapeutics Corporation
 Showing the most relevant articles for your search:NASDAQ:BCTX

Your Recent History

NASDAQ
TSLA
Tesla
ASX
XJO
S&P ASX 200
ASX
ANZ
Australia And New Zealan...
FX
GBPAUD
Sterling vs AUD
COIN
BTCUSD
Bitcoin
ASX
FMG
Fortescue
ASX
NCM
Newcrest Mining
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
ASX
NAB
National Australia Bank
ASX
TLS
Telstra
ASX
BHP
BHP
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved